Colposcopy Market Size By Product Type (Optical, Digital), By Mobility (Fixed, Portable, Handheld), By Area of Diagnosis (Pelvic, Oral), By End-use (Hospitals, Clinics, Diagnostic Centers), COVID-19 Impact Analysis, Regional Outlook, Product Potential, Competitive Market Share & Forecast, 2021 – 2027

Industry Trends

Colposcopy Market size exceeded USD 190 million in 2020 and is anticipated to grow at over 3.9% CAGR between 2021 and 2027. The market growth is attributable to factors such as the high burden of cervical cancer cases, rapidly growing geriatric population and technological advancements in colposcopy. For instance, DYSIS colposcopy uses digital imaging to more accurately define areas of high-grade disease on the cervix. Thus, with intuitive functionality, the examination process becomes fast, easy, accurate and highly efficient, thereby fostering the product demand. Furthermore, developing countries are focusing on increasing the reach of cancer screening programs which in turn are expected to boost the adoption of colposcopy and drive the market expansion.
 

Get more details on this report - Request Free Sample PDF
 

The spread of the COVID-19 pandemic across the globe has negatively impacted the market by disrupting the spectrum of cancer care in 2020. The pandemic has impacted every aspects of cancer care and research, as several countries across the global classified cancer screening and care as a relatively low-priority service. For instance, the government of Scotland delayed cancer related surgeries and suspended screening programs such as for cervical, bowel and breast cancer. Thus, the unprecedented effect of COVID-19 will have a negative impact on colposcopy diagnosis and procedure outcomes in the short term.
 

Increasing prevalence of cervical cancer will propel the demand for early diagnosis

Growing demand for early diagnostic techniques coupled with rising patient pool of cervical cancer are among the key factors that are fueling the colposcopy market progression. There is a high mortality rate from cervical cancer worldwide. For instance, as per the World Health Organization (WHO) report, cervical cancer claimed over 604,00 new cases in 2018 across the globe. In addition, around 90% of deaths occurred in low- and middle-income countries. This high mortality rate can be managed by early diagnostics and screening programs helping in detection of disease at an early phase, thereby augmenting the industry expansion.
 

High cost of colposcopy may slow down the market value

The high cost of colposcopes and its procedure cost may slow down the industry growth in the coming years. For instance, the cost of colposcope ranges from USD 2,000 to USD 8,000. The colposcopy procedure typically costs about USD 100 to USD 500 or more with an additional USD 200 to USD 300 laboratory fee if a biopsy is done as part of the procedure. Thus, high & increasing product and procedure cost may hamper the market demand in the future. Lower insurance coverage for cancer treatment in developing economies will further restrict the market revenue during the forecast period.
 

Advancements in digital colposcopy and user-friendly nature of such device will spur the segment growth

Get more details on this report - Request Free Sample PDF
 

The digital colposcopy segment accounted for USD 110.9 million in 2020 led by its advancements in digital camera technology and high-definition lenses that offer a tremendous leap forward for medical testing and diagnoses. For instance, the Lutech LT-300 SD digital video colposcopy system is easier to control & operate, less strenuous on the body and provides a data uploading, storage and retrieval process. Therefore, such user-friendly modality provides more visual clarity and motion pictures that help in accurate diagnosis.
 

Portable colposcope is slated to dominate the market due to its various advantages

The portable segment captured 44.3% of the colposcopy market share in 2020 owing to the advantages of portable colposcopy. The advantages include ease of installation and movement within medical settings, better result reproducibility, the ability to produce high-definition images and stable cervix examinations. Additionally, increasing usage of portable devices to perform colposcopy that can potentially improve the cervical cancer screening in low- and middle-income countries where ready access to colposcope is limited.
 

Pelvic segment will showcase significant industry revenue

The pelvic segment is poised to witness 4% growth rate and will reach USD 222.3 million by 2027. Pelvic colposcopy examinations are used to analyse inflammation, infection, cancerous changes, and traumatic injuries in vagina and cervix. The high segment expansion is attributed to the increasing burden of cervical cases coupled with screening programmes across the world.
 

Availability of various technologically advanced devices and increasing hospital admission will positively influence the segment progression

The hospitals segment was valued at USD 111 million in 2020. High acceptance rates for technologically advanced biopsy and utilization of colposcopy for early diagnosis of cervical cancer will increase the number of diagnosis carried out in hospital settings. Moreover, as per the National Health Expenditures report 2019, out of the total healthcare expenditures, 32% accounts to hospital care and majority of the admissions to hospital are done for oncology treatments including cervix uteri. This has increased the admissions, usage of treatment and procedure in hospital settings, thereby enhancing the industry demand.
 

Increasing incidence of cervical cancer disease along with rising geriatric population in APAC region will stimulate the market growth

Get more details on this report - Request Free Sample PDF
 

Asia Pacific region dominated the overall colposcopy market in 2020 on account of the rising incidence of cervical cancer along with growing geriatric population base in the region. For instance, China and India together contribute more than one third of the global cervical cancer cases with nearly 109,741 cases in China and 123,907 cases in India in 2020. Such exponential rise in the number of cervical cancer cases will drive the demand for cancer diagnostic and treatment, thereby impelling the market expansion over the forecast timeframe. Furthermore, presence of key market players along with their R&D activities for new product development as well as technological advancements are the few other factors that largely favor the regional growth.
 

Growth strategies of market leaders are focused on increasing the customer base

A few key companies operating in the market are Olympus Corporation, DYSIS Medical, CooperSurgical Inc, ATMOS, Karl Kaps, Carl Zeiss, Seiler Instruments and MedGyn among others. These market players are focusing on numerous strategies such as mergers, acquisitions, partnerships, new product launches, and collaborations to increase their revenue share.
 

Recent industry developments:

• In July 2021, DYSIS Medical announced its new compact and portable colposcope design with Computer-Aided Cervical Mapping technology. With the help of latest innovative technology, the device help healthcare professional to detect cervical lesions more clearly. This strategy boosted the company’s product portfolio and generated more customers for colposcopy diagnosis.
   
• In January 2019, MobileODT partnered with Genworks and Apollo Hospitals to deliver its FDA-cleared smart mobile colposcope. The partnership aimed to perform the first large-scale pilot of Augmented Intelligence for use in the screening of cervical cancer. This partnership strategy helped company to maintain long term business relation and strengthen the market position.
   

The colposcopy market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:

Market, By Product Type

• Optical
• Digital

Market, By Mobility

• Fixed
• Portable
• Handheld

Market, By Area of Diagnosis

• Pelvic
• Oral

Market, By End-use

• Hospitals
• Clinics
• Diagnostic centers

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
• Asia Pacific
  • China
  • India
  • Japan
  • Indonesia
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • South Africa
  • Egypt